A. Kretzschmar

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial (2009)

Link, H, Kohne, C. H, Stahl, M, Kretzschmar, A, Steinbach, S, ...

Platinum/taxane combinations are widely used in patients with carcinoma of unknown primary (CUP), yielding response rates of 30% and median overall survival of 9-11 months in selected patients. Yet...

Identification and characterization of IL-6-regulated ncRNAs (2009)

Grollmütz, N., Brocke-Heidrich, K., Jahndel, V., Schramedei, K., Hackermüller, J., Kretzschmar, A., ...

Long non-protein coding RNAs in oncogenic pathways (2009)

Hackermüller, J., Brocke-Heidrich, K., Reiche, K., Kretzschmar, A., Schutt, K., Ahnert, P., ...

Non-protein coding RNAs as highly specific biomarkers for cancer (2009)

Schutt, K., Horn, F., Ullmann, K., Kretzschmar, A., Hackermüller, J.

Transcriptome profiling reveals many novel p53-regulated human non-coding RNAs (2009)

Böhlig, L., Hackermüller, J., Rose, D., Reiche, K., Kretzschmar, A., Stadler, P.F., ...

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study (2009)

Van Cutsem, E., Rivera, F., Berry, S., Kretzschmar, A., Michael, M., DiBartolomeo, M., ...

Background: Bevacizumab significantly improves survival when added to chemotherapy for metastatic colorectal cancer (mCRC). The Bevacizumab Expanded Access Trial (BEAT) evaluated the safety and...

Performance of a fast fiber based UV/Vis multiwavelength detector for the analytical ultracentrifuge (2008)

Strauss, H. M., Karabudak, E., Bhattacharyya, S., Kretzschmar, A., Wohlleben, W., Cölfen, H.

Induction of microRNA-21 contributes to the oncogenic potential of Stat3 (2007)

Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A., ...

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial (2006)

Karthaus, M., Kretzschmar, A., Kröning, H., Biakhov, M., Irwin, D., Marschner, N., ...

Background: Cancer patients receiving chemotherapy experience thromboembolic complications associated with the use of long-term indwelling central venous catheters (CVCs). This prospective,...

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial (2005)

Karthaus, M., Kretzschmar, A., Kröning, H., Biakhov, M., Irwin, D., Marschner, N., ...

Background: Cancer patients receiving chemotherapy experience thromboembolic complications associated with the use of long-term indwelling central venous catheters (CVCs). This prospective,...

X-ray computed tomography to quantify tree rooting spatial distributions (1999)

Pierret, A, Capowiez, Y, Moran, CJ, Kretzschmar, A

Poor root development due to constraining soil conditions could be an important factor influencing health of urban trees. Therefore, there is a need for efficient techniques to analyze the spatial...

X-ray computed tomography to quantify tree rooting spatial distributions (1999)

Pierret, A, Capowiez, Y, Moran, CJ, Kretzschmar, A

Poor root development due to constraining soil conditions could be an important factor influencing health of urban trees. Therefore, there is a need for efficient techniques to analyze the spatial...

X-ray computed tomography to quantify tree rooting spatial distributions

Pierret, A, Capowiez, Y, Moran, CJ, Kretzschmar, A

Poor root development due to constraining soil conditions could be an important factor influencing health of urban trees. Therefore, there is a need for efficient techniques to analyze the spatial...

Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.

Köhne, C. H., Thuss-Patience, P., Friedrich, M., Daniel, P. T., Kretzschmar, A., Benter, T., ...

Two patients with proven 5-fluorouracil (5-FU)-associated cardiotoxicity were treated with the specific thymidylate synthase inhibitor raltitrexed safely, without evidence of cardiotoxicity....